Deutsche Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.81M Buy
594,995
+289,374
+95% +$2.34M ﹤0.01% 1250
2025
Q1
$2.56M Buy
305,621
+171,735
+128% +$1.44M ﹤0.01% 1570
2024
Q4
$1.06M Buy
133,886
+45,066
+51% +$357K ﹤0.01% 2179
2024
Q3
$739K Buy
88,820
+21,064
+31% +$175K ﹤0.01% 2224
2024
Q2
$430K Buy
67,756
+8,821
+15% +$56K ﹤0.01% 2371
2024
Q1
$357K Buy
58,935
+1,664
+3% +$10.1K ﹤0.01% 2470
2023
Q4
$348K Sell
57,271
-1,454
-2% -$8.83K ﹤0.01% 2529
2023
Q3
$248K Sell
58,725
-231,242
-80% -$976K ﹤0.01% 2612
2023
Q2
$899K Sell
289,967
-19,071
-6% -$59.1K ﹤0.01% 2051
2023
Q1
$430K Buy
309,038
+15,558
+5% +$21.6K ﹤0.01% 2582
2022
Q4
$584K Buy
293,480
+689
+0.2% +$1.37K ﹤0.01% 2354
2022
Q3
$591K Buy
292,791
+508
+0.2% +$1.03K ﹤0.01% 2276
2022
Q2
$929K Sell
292,283
-6,846
-2% -$21.8K ﹤0.01% 2230
2022
Q1
$1.25M Sell
299,129
-6,433
-2% -$26.8K ﹤0.01% 2202
2021
Q4
$1.46M Buy
305,562
+244,030
+397% +$1.17M ﹤0.01% 2186
2021
Q3
$328K Sell
61,532
-1,843
-3% -$9.82K ﹤0.01% 3275
2021
Q2
$324K Sell
63,375
-4,347
-6% -$22.2K ﹤0.01% 3471
2021
Q1
$456K Sell
67,722
-6,034
-8% -$40.6K ﹤0.01% 3144
2020
Q4
$337K Sell
73,756
-7,061
-9% -$32.3K ﹤0.01% 3129
2020
Q3
$313K Sell
80,817
-107,026
-57% -$415K ﹤0.01% 2911
2020
Q2
$895K Buy
187,843
+123,663
+193% +$589K ﹤0.01% 2286
2020
Q1
$224K Sell
64,180
-117,688
-65% -$411K ﹤0.01% 2862
2019
Q4
$875K Buy
181,868
+68,009
+60% +$327K ﹤0.01% 2434
2019
Q3
$329K Buy
113,859
+24,085
+27% +$69.6K ﹤0.01% 2871
2019
Q2
$641K Sell
89,774
-171,700
-66% -$1.23M ﹤0.01% 3088
2019
Q1
$3.7M Buy
261,474
+42,772
+20% +$606K ﹤0.01% 2056
2018
Q4
$2.96M Buy
218,702
+21,999
+11% +$298K ﹤0.01% 2139
2018
Q3
$4.37M Sell
196,703
-3,069
-2% -$68.1K ﹤0.01% 2289
2018
Q2
$3.28M Buy
+199,772
New +$3.28M ﹤0.01% 2609